Mild cognitive impairment (MCI) is an irreparable progressive neuro-degenerative disorder, which seems to be a precursor to Alzheimer’s disease (AD) that may lead to dementia in elderly people. It is a major public health challenge for healthcare in the 21st century. Because there is no curative or therapy to halt or reverse the course of MCI, early identification is critical for successful treatment programs to enhance patients’ quality of life. Currently, Electroencephalography (EEG) has been emerged as an efficient tool to investigate MCI. Traditional methods for finding MCI from EEG data use shallow machine learning-based architectures that cannot find important biomarkers in deep, hidden layers of the data and also have trouble dealing with a large amount of EEG data. To reduce this issue, this research will use EEG data to provide a deep learning-based framework using the Long Short-term Memory (LSTM) model for effective identification of MCI individuals from healthy volunteers (HV). The suggested framework consists of four phases: denoising, segmentation, downsampling, uncovering deep hidden features using the LSTM model, and identifying MCI patients with the sigmoid classifier. This study has designed 20 different LSTM models and investigated them to a publicly available MCI database to find out the best one. After performing 5-fold cross validation, the best model achieved 96.41% of accuracy, 96.55% of sensitivity and 95.95% of specificity. The proposed LSTM-based deep learning model provides a robust biomarker and guide technologists to create a new automatic diagnosis system for MCI detection.
Coronavirus disease (COVID-19) has been the most challenging public health issue during the past years. The current computer-aided methods of COVID19 detection face difficulty to distinguish between COVID19 and pneumonia since they share common symptoms. Traditional methods for solving binary classification problems with COVID-19 classes are limited in their calibre to balance efficiency and accuracy. On the other hand, medical devices like reverse transcription polymerase chain reaction (RT-PCR) take longer than an hour to produce test results, and Rapid Antigen Testing (RAT) is less effective at detecting COVID-19 because it can produce false positive or false negative results. The biggest challenges here are efficiency and accuracy. To address these issues, this study introduces a novel deep multi-layer COVID19 chest X-ray based lung contamination recognition network (XCR-Net) to detect COVID-19, pneumonia, and normal individuals. Our proposed XCR-Net has been tested with five different chest X-ray datasets, having normal, COVID19, and pneumonia case chest X-ray images, and the consistency of XCR-Net has been verified by a 10-fold cross validation scheme. This multi-class study reports the class-wise and overall performance of XCR-Net, and it outperforms all other multi-class COVID-19 endeavours. Future biomedical researchers and IT professionals will be able to advance chest X-ray research with the help of the envisioned XCR-Net.